Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

value

- PMLiVE

EC gives green light to new 6-in-1 childhood vaccine from Sanofi, MSD

Hexyon/Hexacima protects against diphtheria, DTP, hepatitis B, polio, meningitis and Haemophilus influenzae type B

- PMLiVE

Switzerland and pharma forge pricing and access pact

Prices of 2,500 drugs set to fall when price referencing scheme begins

- PMLiVE

GSK’s four-strain flu vaccine approved in Germany and UK

Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK

- PMLiVE

Eastern Europe facing ‘health crisis’

Disparity between east and west in male life expectancy is larger than 40 years ago

- PMLiVE

WHO claims $1.3bn annual funding gap for tuberculosis research

Says action needs to be taken now to halt spread of multi-drug resistant TB

- PMLiVE

GW Pharma says German Sativex pricing “unacceptable”

May pull MS drug from market

- PMLiVE

A helping hand with innovation

As healthcare innovation evolves, pharma is beginning to look beyond its own four walls to embrace collaboration

The search for a cancer cure demands collaboration – J&J research head

Challenging pharma environment means organisations need to work together to innovate

- PMLiVE

The future of market access through a communications lens

Communications will play a pivotal role in helping pharma to define the value agenda

- PMLiVE

Johnson & Johnson opens London innovation centre

Centre will serve as European hub for its healthcare innovation efforts

- PMLiVE

MHRA launches virtual ‘innovation office’

Aims to smooth regulatory pathway for companies developing novel medicines, devices or technology

- PMLiVE

WHO warns of medicines shortage in Syria

Conflict affecting production and import of essential drugs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links